Reduced clinical severity during 2022 Shanghai Spring epidemic of SARS-CoV-2 omicron BA.2 variant infection-an integrated account of virus pathogenicity and vaccination effectiveness
1 Department of Emergency Medicine, Clinical Center for Bio-Therapy, Department of Biostatistics, and Department of Urology, Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Fudan University, China.
2 Department of Respiratory and Critical Care Medicine, Shanghai Pudong Hospital, Fudan University, China.
3 Department of Pulmonology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, China.
4 Key Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China.
5 Shanghai Public Health Clinical Center, Fudan University, China.
6 Department of Biostatistics, School of Public Health, Key Laboratory of Public Health Safety of Ministry of Education, and Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, China.
7 Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Institute of Virology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, School of Medicine, Shanghai Jiao Tong University, China.
8 State Key Laboratory of Genetic Engineering, Fudan Microbiome Center, School of Life Sciences, Fudan University, China.
9 Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, China.